EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease

Valentina Peta, Marianne Ziol, Françoise Imbert‐Bismut, Angela Sutton, Denis Monneret, Mona Munteanu, Frederic Charlotte, Olivier Lucidarme, Yen Ngo, An Ngo, Olivier Deckmyn, Tam Pham und 5 weitere

GastroHep · 2019

DOI: 10.1002/ygh2.339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GastroHep, 2019. Verfasst von Valentina Peta und 16 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Peta, V., Ziol, M., Imbert‐Bismut, F., Sutton, A., Monneret, D., Munteanu, M., Charlotte, F., Lucidarme, O., Ngo, Y., Ngo, A., Deckmyn, O., Pham, T., Thabut, D., Ratziu, V., Housset, C., Poynard, T., & Nahon, P. (2019). External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease. GastroHep. https://doi.org/10.1002/ygh2.339

Vancouver

Peta V, Ziol M, Imbert‐Bismut F, Sutton A, Monneret D, Munteanu M, et al. External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease. GastroHep. 2019. doi:10.1002/ygh2.339

BibTeX
@article{Peta2019,
  author = {Peta, Valentina and Ziol, Marianne and Imbert‐Bismut, Françoise and Sutton, Angela and Monneret, Denis and Munteanu, Mona and Charlotte, Frederic and Lucidarme, Olivier and Ngo, Yen and Ngo, An and Deckmyn, Olivier and Pham, Tam and Thabut, Dominique and Ratziu, Vlad and Housset, Chantal and Poynard, Thierry and Nahon, Pierre},
  title = {External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease},
  journal = {GastroHep},
  year = {2019},
  doi = {10.1002/ygh2.339}
}
Kostenlos starten →